JP3419728B2 - Food composition - Google Patents
Food compositionInfo
- Publication number
- JP3419728B2 JP3419728B2 JP2000058112A JP2000058112A JP3419728B2 JP 3419728 B2 JP3419728 B2 JP 3419728B2 JP 2000058112 A JP2000058112 A JP 2000058112A JP 2000058112 A JP2000058112 A JP 2000058112A JP 3419728 B2 JP3419728 B2 JP 3419728B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- fermented
- millet
- hair
- isoflavone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、脱毛の減少に極め
て効果的且つ安全な、髪の育成に効果のある食品組成物
に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a food composition that is extremely effective and safe for reducing hair loss and that is effective for growing hair.
【0002】[0002]
【従来の技術】脱毛症の原因はホルモンバランスの崩
れ、ストレス、老化、血行不良などの要因が複雑に絡み
合って生じていると考えられており、従来より種々の毛
髪用化粧料及び養毛料が用いられてきている。これら毛
髪用化粧料及び養毛料には、センブリエキス、朝鮮人参
エキス等の頭皮の皮膚細胞賦活物質、トウガラシエキ
ス、ニコチン酸誘導体などの頭皮の血行促進物質、エス
トラジオール、エストロンなどの女性ホルモンがいずれ
も外用として使われてきた。2. Description of the Related Art It is considered that the cause of alopecia is a complex intertwining of factors such as hormonal imbalance, stress, aging, poor blood circulation, and various hair cosmetics and hair nourishing agents have been conventionally used. Has been used. In these hair cosmetics and hair nourishing agents, all of the scalp skin cell activators such as senburi extract and ginseng extract, scalp blood circulation-promoting substances such as capsicum extract and nicotinic acid derivative, and female hormones such as estradiol and estrone are included. It has been used for external use.
【0003】しかし、従来より毛髪用化粧料及び養毛料
として使用されている細胞賦活物質は、低濃度では皮膚
への浸透性が低く、且つ単独では充分に効果が発揮され
ないという問題点がある。また、同様に用いられている
血行促進物質は皮膚刺激が強く、その配合量に制限があ
り、血行促進の持続時間が短いという欠点がある。また
女性ホルモン剤は全身的作用が懸念され、その配合量に
制限があり、充分な効果を発揮し得なかった。However, the cell activating substances which have been conventionally used as cosmetics for hair and hair nourishing have a problem that their permeability to the skin is low at a low concentration, and that they are not sufficiently effective alone. Further, the blood circulation-promoting substances used in the same manner have the drawbacks that they have strong skin irritation, their amount is limited, and the duration of blood circulation promotion is short. In addition, the female hormone drug is concerned about the systemic effect, and its compounding amount is limited, so that it cannot exert a sufficient effect.
【0004】最近、毛髪用化粧料及び養毛料として、安
全性の面からハーブ等の植物抽出物が注目されている。
例えば、スギナ抽出物を有効成分とするもの(特開平11
-124318号、同10-265347号)、イチョウ抽出物を有効成
分とするもの(登録第2811479号、同第2835970号、特開
平10-287531号、同3-133919号)などの外用剤を挙げる
ことができる。スギナ抽出物に関しては古来よりヨーロ
ッパで髪爪によいハーブとして茶剤に用いられてきてお
り(小学館 ハーブ大全 p.61 1990発行)、またイチョ
ウ葉抽出物は血行促進作用が知られている。しかしなが
ら、これらを配合した外用剤を用いても、接触性皮膚炎
の問題や、洗髪および汗をかくことで落ちてしまうとい
う欠点があり、有効性の面で実用上充分に満足できるも
のではなかった。[0004] Recently, plant extracts such as herbs have been attracting attention as a cosmetic for hair and a hair nourishing agent from the viewpoint of safety.
For example, those containing horseradish extract as an active ingredient (Japanese Patent Application Laid-Open No. 11-242242)
-124318, 10-265347), those containing Ginkgo biloba extract as an active ingredient (Registered 2811479, 2835970, JP-A-10-287531, 3-133919) and the like. be able to. The horse mackerel extract has been used as a good herb for nails in Europe since ancient times (published by Shogakukan Herb Taizen p.61 1990), and ginkgo biloba extract is known to promote blood circulation. However, even if an external preparation containing these is used, there is a problem of contact dermatitis and the drawback of falling off by washing hair and sweating, and it is not practically sufficiently satisfactory in terms of effectiveness. It was
【0005】又、脱毛の一因として考えられているホル
モンバランスの崩れに対し、エストラジオールなどの女
性ホルモン類を有効成分として配合するもの(登録第28
35970号)が挙げられる。しかしながら、女性ホルモン
剤は乳がんなどの全身的作用が懸念され、その配合量に
制限があり、充分な効果を発揮し得なかった。In addition, for the disruption of hormone balance, which is considered to be one of the causes of hair loss, a female hormone such as estradiol is added as an active ingredient (Registration No. 28.
No. 35970). However, female hormone preparations are not possible to exert a sufficient effect due to concern about systemic effects such as breast cancer and the limited amount of the combination.
【0006】また、発毛及び育毛のためには種々の栄養
補給も必要である。これに関しては毛髪組成物として知
られるケラチン及び脱毛予防として知られるパントテン
酸を有効成分として配合するもの(特開平10-17427)が
挙げられる。しかしながら、細胞への栄養補給は末梢の
血液を介して行われるものであり、外用としてこれら栄
養成分を補っても充分な効果を得られるものではなかっ
た。Various nutritional supplements are also required for hair growth and hair growth. In this regard, keratin, which is known as a hair composition, and pantothenic acid, which is known as a hair loss preventive, are added as active ingredients (JP-A-10-17427). However, nutritional supply to cells is carried out via peripheral blood, and sufficient effects cannot be obtained even when these nutritional components are supplemented externally.
【0007】これまで育毛、発毛を促す薬剤は毛髪用化
粧料及び養毛料等の名称でいずれも外用剤として用いら
れてきた。しかしながら、毛髪は本来、毛細血管に接す
る真皮中の毛乳頭からの司令で生成されるものであり、
このようなメカニズムに着目した場合、有効成分を外用
しても毛乳頭にまで届く成分は少なく、むしろ内服する
ことによって有効であると考えられる。Up to now, agents for promoting hair growth and hair growth have been used as external preparations under the names such as hair cosmetics and hair nourishing agents. However, the hair is originally generated by the command from the papilla in the dermis, which is in contact with the capillaries,
Focusing on such a mechanism, even if the active ingredient is applied externally, few ingredients reach the dermal papilla, and it is considered that it is effective by taking it internally.
【0008】内服する毛髪用健康食品としてはキビ抽出
物を有効成分とするもの(登録1688371)が挙げられ
る。しかしながら、抜け毛、脱毛症に悩む患者は末梢血
行不良である人が大変多く、従って末梢血行不良の状態
で有効成分を補っても頭皮下の毛乳頭にまで届かないの
が現状である。血行促進成分としてはビタミンEが知ら
れており、この成分を含むものとして小麦胚芽油を配合
しているが、小麦胚芽油中のビタミンE量は1gあたり
1.5mgと非常に少なく、ビタミンEを栄養所要量程度摂
取するためでも、大量に小麦胚芽油を取らなくてはなら
ない。また、男性型脱毛症は5-αリダクターゼによって
男性ホルモンであるテストステロンより還元されたジヒ
ドロテストステロンが主原因であると考えられている。
5-αリダクターゼ阻害成分としてイソフラボンを配合し
た特許(登録2791673)があるが、末梢血行不良の状態
で本成分を補っても毛乳頭にまで届かないのが現状であ
る。As a health food for hair to be taken internally, one containing a millet extract as an active ingredient (Registration 1688371) can be mentioned. However, there are many patients suffering from hair loss and alopecia who have poor peripheral blood circulation, and therefore, even if an active ingredient is supplemented in the state of poor peripheral blood circulation, it does not reach the dermal papilla under the scalp. Vitamin E is known as a blood circulation promoting component, and wheat germ oil is blended to contain this component. The amount of vitamin E in wheat germ oil is 1 g per 1 g.
It is a very small amount of 1.5 mg, and wheat germ oil must be taken in large amounts even to obtain the required amount of vitamin E. Further, androgenetic alopecia is considered to be mainly caused by dihydrotestosterone which is reduced by the male hormone testosterone by 5-α reductase.
There is a patent (Registered 2791673) that contains isoflavone as a 5-α-reductase inhibitor, but the fact is that even if this component is supplemented in the state of poor peripheral blood circulation, it does not reach the dermal papilla.
【0009】[0009]
【発明が解決しようとする課題】従って、本発明の目的
は外用剤の欠点を克服した安全性且つ効果の高い育毛効
果に優れた毛髪用食品を提供することにある。SUMMARY OF THE INVENTION Therefore, an object of the present invention is to provide a food for hair which has a safe and highly effective hair-growth effect and which overcomes the drawbacks of the external preparation.
【0010】[0010]
【課題を解決するための手段】本発明者はかかる実情に
おいて、鋭意研究を行った結果、特定成分を組み合わせ
て含有する食品組成物は外用剤の欠点を克服した類希な
る有効性を持ち、且つ極めて安全性が高いものであるこ
とを見出し、本発明を完成させた。すなわち、本発明
は、キビ、イチョウ葉抽出物及びイソフラボンを含有す
ることを特徴とする食品組成物である。好ましくは、キ
ビ1質量部に対して、イチョウ葉抽出物0.1−5質量
部、及びイソフラボン0.001−3質量部、より好ま
しくはキビ1質量部に対して、イチョウ葉抽出物0.4
−4質量部、イソフラボン0.02−2質量部を含有す
ることを特徴とする食品組成物である。Under the above circumstances, the present inventor has conducted diligent research, and as a result, a food composition containing a combination of specific ingredients has an unparalleled effectiveness overcoming the drawbacks of external preparations. Moreover, they have found that they are extremely safe and have completed the present invention. That is, the present invention is a food composition containing millet, ginkgo biloba extract and isoflavone. Preferably, 0.1-5 parts by mass of ginkgo biloba extract and 0.001-3 parts by mass of isoflavone per 1 part by mass of millet, and more preferably 0. Four
-4 parts by mass and isoflavone 0.02-2 parts by mass, which is a food composition.
【0011】[0011]
【発明の実施の態様】キビ(Panicum milliaceum L)は
各種ミネラルを豊富に含み、栄養価の高い食糧として古
くより常食されてきたが、最近では余り食されていな
い。また、ヨーロッパでは髪や爪によいハーブとして伝
統的に外用または内服されてきたハーブである。本発明
において、キビとは例えばキビ(Panicum milliaceum
L)の種子若しくは果実又はキビ(Panicum milliaceum
L)の種子若しくは果実等から抽出した抽出物である。
抽出溶媒としては水、熱水、またはメタノール、エタノ
ール、プロパノール、イソプロパノール、ブタノールな
どの一価のアルコール若しくはそれらの水溶液など、ま
たはアセトン、ヘキサンなど、従来食用として用いられ
る植物の抽出溶媒として知られているものなら特に限定
されるものではなく使用することができる。本発明にお
けるキビとしては、キビの種子又は果実をそのまま粉砕
したもの、完熟したキビ乾燥種子の抽出物を分離濃縮
し、賦形剤を添加し、乾燥することにより得られるも
の、またはそれを粉末化したものが用いられる。BEST MODE FOR CARRYING OUT THE INVENTION Millet (Panicum milliaceum L) is rich in various minerals and has been a staple food for a long time as a nutritious food, but it has not been eaten much recently. In Europe, it is a herb that has been traditionally applied externally or internally as a good herb for hair and nails. In the present invention, millet means, for example, millet (Panicum milliaceum
L) seeds or fruits or millet (Panicum milliaceum)
It is an extract extracted from the seed or fruit of L).
As the extraction solvent, water, hot water, or monohydric alcohols such as methanol, ethanol, propanol, isopropanol, butanol or an aqueous solution thereof, or acetone, hexane, etc., conventionally known as an edible plant extraction solvent. If it is present, it is not particularly limited and can be used. As the millet in the present invention, those obtained by crushing millet seeds or fruits as they are, separating and concentrating the extract of ripe millet dry seeds, adding an excipient and drying, or a powder thereof. The one that is converted is used.
【0012】イチョウ葉抽出物はイチョウ(Ginkgo bil
oba L)の葉から抽出されて得られるものである。例え
ばイチョウの葉を水や有機溶剤あるいは水−有機溶剤混
合溶媒で抽出した抽出分、またはそれを粉末化したもの
が用いられる。本発明に使用するイチョウ葉抽出物は、
フラボノイド類を20%以上、テルペノイド類を5%以
上含むものあるいはその両者を主成分として含有するも
のであれば何でも使用することができる。このようなイ
チョウ葉抽出物は任意の公知の技術で製造することがで
きる。例えば乾燥イチョウ葉を含水低級アルコールで抽
出した後、得られた抽出物より脂溶性有機溶媒を用いて
低極性化合物を除くか、あるいはさらに水と混合しない
有機溶媒により抽出するといった公知の方法により製造
することができる。[0012] Ginkgo biloba extract is Ginkgo bil.
oba L) is obtained by extraction from leaves. For example, an extract obtained by extracting ginkgo biloba leaves with water, an organic solvent or a water-organic solvent mixed solvent, or a powder thereof is used. The ginkgo biloba extract used in the present invention is
Any flavonoids containing 20% or more, terpenoids containing 5% or more, or both as the main components can be used. Such ginkgo biloba extract can be produced by any known technique. For example, it is produced by a known method in which dried ginkgo leaves are extracted with a hydrous lower alcohol, and then low polar compounds are removed from the obtained extract by using a fat-soluble organic solvent, or by extraction with an organic solvent which is not mixed with water. can do.
【0013】イチョウ葉抽出物は、フラボン配糖体、テ
ルペン類等を含有し、血管拡張、血流増大、血管系の老
化防止などに有効とされており、古くから鎮咳,去痰、
解毒、滋養などの目的で民間薬として用いられている。
また、ヨーロッパでは脳循環改善薬として医薬品に使用
されている。医薬品の摂取量としては一日3回、一回40
-80mgが設定されており、末梢血管拡張に関する有効性
が確認されている。The ginkgo biloba extract contains flavone glycosides, terpenes and the like, and is said to be effective for vasodilation, increase of blood flow, prevention of aging of vascular system, and antitussive, expectorant,
It is used as a folk medicine for detoxification and nutrition.
It is also used as a cerebral circulation improving drug in Europe. The intake of medicines is 40 times, 3 times a day
-80 mg is set, and its efficacy on peripheral vasodilation has been confirmed.
【0014】本発明におけるイソフラボンは、イソフラ
ボン骨格を持つ化合物であり、例えばdaidzin、glyciti
n、genistin、daidzein、glycitein、genistein、6”-o
-acetyl-daidzin、6”-o-acetyl-glycitin、 6”-o-ace
tyl-genistin、6”-o-malonyl-daidzin、6”-o-malonyl
-glycitin、6”-o-malonyl-genistin等、また、これら
が微生物発酵によりサクシニル化、ヒドロキシル化等の
何らかの修飾をされたもの、あるいはこれらを酵素処理
やその他の方法によって修飾したものが挙げられる。本
発明においてはイソフラボンを少なくとも0.1質量%
以上含有するものが好ましく、例えば大豆や大豆胚軸、
葛、レッドクローバー、オウギをそのまま乾燥、粉砕し
たもの、またそれらから抽出工程を経て分離、精製した
もの、あるいは、大豆や大豆胚軸、葛、レッドクローバ
ー、オウギを粉砕し、微生物、例えば納豆菌あるいは黒
麹菌や紅麹菌、黄麹菌などの麹菌により発酵させたもの
を適当な手段により粉末化したもの、またはそれらから
抽出工程などを経て分離、精製したものがあり、それら
はそのままの形態で本発明の原料として用いることがで
きる。例えば脱脂加工大豆および大豆胚芽を蒸煮し、冷
却後種麹を加え混合し、製麹を行った後、加水分解、殺
菌、乾燥、粉砕したものを使用することができる。The isoflavone in the present invention is a compound having an isoflavone skeleton, such as daidzin and glyciti.
n, genistin, daidzein, glycitein, genistein, 6 ”-o
-acetyl-daidzin, 6 ”-o-acetyl-glycitin, 6” -o-ace
tyl-genistin, 6 ”-o-malonyl-daidzin, 6” -o-malonyl
-glycitin, 6 "-o-malonyl-genistin, etc., and those modified by microbial fermentation such as succinylation and hydroxylation, or those modified by enzymatic treatment or other methods In the present invention, at least 0.1% by mass of isoflavone is used.
Those containing above are preferable, for example, soybean or soybean hypocotyl,
Kuzu, red clover, sugi which are dried and crushed as they are, and those which have been separated and purified through an extraction step from them, or soybeans, soybean hypocotyls, kuzu, red clover, sugi which have been crushed, and microorganisms such as natto Alternatively, those fermented with Aspergillus niger, Aspergillus niger, or Aspergillus oryzae may be pulverized by an appropriate means, or may be separated and purified from them through an extraction step, etc. It can be used as a raw material of the invention. For example, defatted soybean and soybean germ can be steamed, cooled, seed koji is added and mixed, and koji-making is performed, followed by hydrolysis, sterilization, drying and crushing.
【0015】イソフラボンはエストロゲン様作用、抗コ
レステロール作用、抗癌作用、骨粗鬆症の予防等、種々
の生理作用を有することが知られている。日本人のイソ
フラボン摂取量は一日あたり平均18mgと諸外国に比べ多
く(FFIJ.,172,83-89 1997)、日本人女性の更年期障害
が比較的軽いことの主要因と考えられている。(Lance
t,339,1233 1992)また、日本の長寿地域である沖縄県
は癌の頻度が低く、この主要因としてイソフラボン摂取
量(一日あたり32mg)の多さが指摘されている。(Will
cox,B,J.,et al:Am. J.Clin.Nutr.,61,901 1995)イソ
フラボンを有効成分とする骨粗鬆症治療薬イプリフラボ
ンは1日あたり600mgの摂取量を設定しているが、
通常ホルモンバランスを整える為には30〜100mg
の摂取が有効なのではないかと考えられている。Isoflavones are known to have various physiological actions such as estrogen-like action, anticholesterol action, anticancer action and prevention of osteoporosis. The average isoflavone intake of the Japanese is 18 mg per day, which is higher than that of other countries (FFIJ., 172,83-89 1997), and it is considered to be the main cause of the relatively mild menopause in Japanese women. (Lance
It has been pointed out that the isoflavone intake (32 mg per day) is a major cause of cancer in Okinawa, which is the longevity region of Japan, and the frequency of cancer is low. (Will
cox, B, J., et al: Am. J.Clin.Nutr., 61,901 1995) Ipriflavone, a therapeutic drug for osteoporosis containing isoflavone as an active ingredient, has a daily intake of 600 mg.
Usually 30 to 100 mg to adjust hormone balance
It is thought that the intake of is effective.
【0016】本発明の組成物における各成分の量は、キ
ビ1質量部に対して、好ましくはイチョウ葉抽出物0.
1−5質量部、イソフラボン0.001−3質量部であ
り、より好ましくはイチョウ葉抽出物0.4−4質量
部、イソフラボン0.02−2質量部である。この範囲
でキビ、イチョウ葉抽出物及びイソフラボンの相乗効果
がより顕著に発揮される。キビ1質量部相当に対して、
イチョウ葉抽出物が0.1質量部未満では本発明の目的
とする効果が必ずしも十分ではなく、5質量部を超えて
もそれ以上の効果は望めない。同様に、イソフラボンは
0.001質量部未満では本発明の目的とする効果が必
ずしも充分ではなく、4質量部を超えてもそれ以上の効
果は望めない。必要に応じて本発明の組成物にビオチ
ン、パントテン酸およびこれらの誘導体、ケラチンなど
を配合してもよい。The amount of each component in the composition of the present invention is preferably 0.
1-5 parts by mass and 0.001-3 parts by mass of isoflavone, more preferably 0.4-4 parts by mass of ginkgo biloba extract and 0.02-2 parts by mass of isoflavone. In this range, the synergistic effect of millet, ginkgo biloba extract and isoflavone is more remarkably exhibited. For 1 part by mass of millet,
If the ginkgo biloba extract is less than 0.1 parts by mass, the effect of the present invention is not sufficient, and if it exceeds 5 parts by mass, no further effect can be expected. Similarly, if the amount of isoflavone is less than 0.001 part by mass, the effect aimed at by the present invention is not necessarily sufficient, and if it exceeds 4 parts by mass, no further effect can be expected. If necessary, biotin, pantothenic acid and derivatives thereof, keratin and the like may be added to the composition of the present invention.
【0017】本発明の食品組成物を製造するには、例え
ばカプセル化する場合は、例えばキビ、イチョウ葉抽出
物、イソフラボン及びミツロウを混合し、ゼラチン及び
グリセリンを混合したカプセル基剤中に充填する。本発
明の食品組成物はカプセルに限らず、常法により、錠
剤、顆粒食品、一般飲料、などの任意の食品とすること
ができる。To produce the food composition of the present invention, for example, when encapsulating, for example, millet, ginkgo biloba extract, isoflavone and beeswax are mixed, and the mixture is filled in a capsule base mixed with gelatin and glycerin. . The food composition of the present invention is not limited to capsules, and can be made into any food such as tablets, granule foods, general beverages, etc. by a conventional method.
【0018】本発明における食品組成物は、キビ、イチ
ョウ葉抽出物及びイソフラボンをそれぞれ単体で摂取し
た場合よりも遥かに効果的に薄毛及び抜け毛の改善効果
を発揮する。そのメカニズムは明らかではないが、頭皮
の末梢血行不良を改善することによって有効成分が確実
に毛根に行き届き、また、弱いエストロゲン様作用によ
ってホルモンバランスの崩れによる脱毛を予防するもの
と考えられる。The food composition of the present invention exerts an effect of improving thinning hair and loss of hair much more effectively than ingesting millet, ginkgo biloba extract and isoflavone alone. Although the mechanism is not clear, it is considered that the active ingredient is surely delivered to the hair root by improving the poor peripheral blood circulation in the scalp, and the hair loss due to the disruption of the hormone balance is prevented by the weak estrogenic action.
【0019】[0019]
【実施例】以下に実施例を示し、本発明を詳細に説明す
るが、本発明の技術的範囲をこれに限定するものではな
い。The present invention will be described in detail below with reference to examples, but the technical scope of the present invention is not limited thereto.
【0020】実施例1〜3、比較例1〜6
表1に示す処方によりキビ、フラボノイド24%及びテ
ルペンラクトン6%を含むイチョウ葉抽出物、イソフラ
ボンからなる原料を混合し、ゼラチン及びグリセリンを
混合したカプセル基剤中に充填し、軟カプセルを得た。
評価法は試料使用前後の洗髪時脱毛本数で判定した。実
施例、比較例ごと各10名(男5、女5)の被験者に対
し、2ヶ月間試料を1日1.6g摂取させ、試料を摂取
する前と2ヶ月摂取後の洗髪時の抜け毛を回収し、その
本数を数えた。効果の判定は各々の期間の差から次のよ
うに表示した。Examples 1 to 3 and Comparative Examples 1 to 6 According to the formulations shown in Table 1, ginkgo biloba extract containing millet, flavonoid 24% and terpene lactone 6%, and a raw material consisting of isoflavone were mixed, and gelatin and glycerin were mixed. It was filled in the capsule base to obtain soft capsules.
The evaluation method was determined by the number of hair loss before and after using the sample. For each of 10 examples (5 males and 5 females) of each of the Examples and Comparative Examples, 1.6 g of the sample was ingested per day for 2 months, and hair loss before and after ingestion of the sample was washed. It was collected and the number was counted. The judgment of the effect was displayed as follows from the difference of each period.
【0021】判定:基準
0:抜け毛本数の減少が10本未満であり、効果がある
とは言えない。
1:抜け毛本数が10本以上減っておりわずかな効果を
認めた。
2:抜け毛本数が40本以上減っておりかなりの効果を
認めた。
3:抜け毛本数が70本以上減っており著しい効果を認
めた。Judgment: Criterion 0: The number of hair loss is less than 10 and cannot be said to be effective. 1: The number of hair loss was reduced by 10 or more, and a slight effect was recognized. 2: The number of hair loss was reduced by 40 or more, and a considerable effect was recognized. 3: The number of hair loss was reduced by 70 or more, and a remarkable effect was recognized.
【0022】10人のパネラーの判定スコアとその合計
を表2に示した。その結果、表2に示すようにキビ、イ
チョウ葉抽出物及びイソフラボンを含む実施例1では9
割の被験者の抜け毛が大幅に減少した。イチョウ葉抽出
物及びイソフラボンがある程度以上になると、実施例
2,3に示すように効果は頭打ちとなった。キビ、イチ
ョウ葉抽出物及びイソフラボン単独の比較例1,2,
3、また三種のうち二種を含む比較例4,5,6は人に
よってわずかに抜け毛数が減少しているが全体的な改善
には至っていない。Table 2 shows the judgment scores of 10 panelists and their totals. As a result, as shown in Table 2, it was 9 in Example 1 containing millet, ginkgo biloba extract and isoflavone.
Hair loss in a relatively small number of subjects was significantly reduced. When the amount of Ginkgo biloba extract and isoflavone exceeded a certain level, the effect reached the ceiling as shown in Examples 2 and 3. Comparative examples 1, 2 of millet, ginkgo biloba extract and isoflavone alone
In Comparative Examples 4, 5 and 6 including 3 and 2 out of 3 types, the number of hair loss is slightly decreased depending on the person, but the overall improvement has not been achieved.
【0023】[0023]
【表1】 [Table 1]
【0024】[0024]
【表2】 [Table 2]
【0025】[0025]
【発明の効果】以上のように、本発明により、脱毛の減
少に極めて効果的かつ安全な、髪の育成に効果のある食
品組成物を提供できる。INDUSTRIAL APPLICABILITY As described above, according to the present invention, it is possible to provide a food composition which is extremely effective in reducing hair loss and safe and which is effective in growing hair.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A23L 1/29 - 1/308 A23L 1/10 A61K 35/78 ─────────────────────────────────────────────────── ─── Continuation of the front page (58) Fields surveyed (Int.Cl. 7 , DB name) A23L 1/29-1/308 A23L 1/10 A61K 35/78
Claims (5)
ンを育毛用有効成分として含有することを特徴とする食
品組成物。1. A food composition comprising millet, ginkgo biloba extract and isoflavone as active ingredients for hair growth .
〜5質量部およびイソフラボンを0.001〜3質量部
含有することを特徴とする食品組成物。 2. 1 part by mass of millet and 0.1 ginkgo biloba extract
~ 5 parts by mass and isoflavone 0.001 to 3 parts by mass
A food composition comprising:
これら各々の抽出物であることを特徴とする請求項1又
は2の食品組成物。Wherein millet, also claim 1, wherein the fruit of millet, it is pulverized or each extract these seeds
Is a food composition of 2 .
胚軸、大豆胚軸発酵物、葛、葛発酵物、レッドクローバ
ー、レッドクローバー発酵物、オウギ、オウギ発酵物、
これら各々より抽出された大豆抽出物、大豆発酵抽出
物、大豆胚軸抽出物、大豆胚軸発酵抽出物、葛抽出物、
葛発酵抽出物、レッドクローバー抽出物、レッドクロー
バー発酵抽出物、オウギ抽出物及びオウギ発酵抽出物か
ら選ばれた1種以上のものとして含まれていることを特
徴とする請求項1、2又は3の食品組成物。4. Isoflavone is soybean, fermented soybean, fermented soybean hypocotyl, fermented soybean hypocotyl, kudzu, fermented kudzu, red clover, fermented red clover, ougi, fermented ougi,
Soybean extract extracted from each of these, soybean fermented extract, soybean hypocotyl extract, soybean hypocotyl fermented extract, kudzu extract,
Kudzu fermentation extract, red clover extract, red clover fermented extract according to claim 1, characterized in that it contains as more than one selected from the Radix Astragali extract and Radix Astragali fermented extract, 2 or 3 Food composition.
か1項の食品組成物。5. The food composition according to claim 1, which is for growing hair.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000058112A JP3419728B2 (en) | 2000-03-03 | 2000-03-03 | Food composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000058112A JP3419728B2 (en) | 2000-03-03 | 2000-03-03 | Food composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001238637A JP2001238637A (en) | 2001-09-04 |
JP3419728B2 true JP3419728B2 (en) | 2003-06-23 |
Family
ID=18578757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000058112A Expired - Lifetime JP3419728B2 (en) | 2000-03-03 | 2000-03-03 | Food composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3419728B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2841102B1 (en) * | 2002-06-21 | 2005-06-24 | USE OF POLYPHENOLS FOR THE PREPARATION OF FOOD COMPLEMENTS USEFUL IN THE TREATMENT OF THE DISORDERS OF THE PILO-SEBACEOUS UNIT | |
JP3830960B1 (en) * | 2005-08-12 | 2006-10-11 | 建仁 河乃 | Hair growth substance |
WO2007083402A1 (en) * | 2006-01-23 | 2007-07-26 | Almado Co., Ltd. | Nutritional supplement for promotion of hair growth and/or hair restoration |
-
2000
- 2000-03-03 JP JP2000058112A patent/JP3419728B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2001238637A (en) | 2001-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0656786B1 (en) | Use of isoflavone phyto-oestrogen extracts of soy or clover | |
JP3502374B2 (en) | Extracts derived from Pueraria mirifica, Butea Superba and / or Mukna Koretch and methods for extracting the same | |
KR100893106B1 (en) | Composition for promoting hair growth | |
CN101415465A (en) | Novel compositions for hair disorders and process of preparation thereof | |
KR100701606B1 (en) | The cosmetic composition with a herb medicine extract and the producing method thereof | |
JP2008525320A (en) | Formulation and treatment for welfare | |
JP2003192605A (en) | Lipase inhibitant | |
CN110624089A (en) | A topical Chinese medicinal composition for promoting hair growth, and its preparation method | |
JP5617110B2 (en) | Oral hair growth promoter | |
KR101407659B1 (en) | A composition for inhibiting testosterone 5-alpha reductase | |
US20060110475A1 (en) | Composition containing in combination at least one bourd oil and at least one borage oil, use thereof as medicine, as dermatological or dermato-cosmetic agent | |
WO2021064132A1 (en) | Treatment of menopausal syndrome and/or symptoms associated with menopause | |
JP3419728B2 (en) | Food composition | |
WO2005107729A1 (en) | Compositions comprising lycopene and phytoestrogen | |
JP2011195502A (en) | Fibroblast proliferation promoter, anti-ageing agent and wrinkle-ameliorating agent | |
Bala et al. | Hibiscus Rosa Sinensis Linn.: A phytochemical and pharmacological review | |
KR100550165B1 (en) | Manufacturing method of water-soluble propolis | |
KR101082819B1 (en) | Functional composition derived from natural material for alleviating atopic dermatitis | |
JP2007186483A (en) | Food product for treatment of menopausal symptom | |
KR100769412B1 (en) | A composition comprising an extract of pr-119 formulation for the prevention and treatment of benign prostatic hyperplasia | |
CN110538308B (en) | Traditional Chinese medicine composition for hair growth and preparation method thereof | |
KR101897720B1 (en) | Cosmetic or pharmaceutical composition for promoting hair growth comprising Tenebrio molitor fractions | |
CN111713623A (en) | Solid beverage and preparation method thereof | |
JP2015044747A (en) | PDE3 inhibitor | |
Udgata et al. | Soybean isoflavones: Remedial nutraceuticals in Indian perspective |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
R150 | Certificate of patent or registration of utility model |
Ref document number: 3419728 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090418 Year of fee payment: 6 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090418 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100418 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100418 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110418 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110418 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120418 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130418 Year of fee payment: 10 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130418 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140418 Year of fee payment: 11 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |